Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

This remarkable launch success is driven predominantly by continued growth and adoption in generalized myasthenia gravis ... also maintained a strong balance sheet, with cash, cash equivalents ...

The number one misdiagnosis for LEMS is myasthenia gravis. And we track these patients ... The number one reason for death of Duchenne’s patient is in fact cardiovascular disease.

The number one misdiagnosis for LEMS is myasthenia gravis. And we track these patients through certain ... The number one reason for death of Duchenne’s patient is in fact cardiovascular disease.

The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and ...

No swallow or voice evaluation or treatment were offered to 83.1% of all individuals with myasthenia gravis, 53% of patients with myasthenia gravis and any speech/swallow dysfunction, 43.8% who ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular ...

THE occurrence of thyrotoxicosis in patients with myasthenia gravis is not rare, over 90 such cases having been reported since the turn of the century. 1,2 Various estimates place the incidence of ...

Beijing — China's Foreign Ministry took issue Monday with a revised U.S. government fact sheet that removed a line on American opposition to independence for Taiwan. The United States "gravely ...

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

The EFSA's caffeine fact sheet says that there's about 90mg of caffeine in an average cup of filter coffee, 80mg in an espresso and 50mg in a black tea, and that an intake of 400mg throughout the ...